Abington Neurological Associates

Summary

Abington Neurological Associates is a medical facility located in Abington, Pennsylvania. This center is recognized for care of Alzheimer's Disease, Dementia, Multiple Sclerosis, Cognitive Impairment, Migraine and other specialties. Abington Neurological Associates is involved with conducting 68 clinical trials across 51 conditions. There are 1 research doctors associated with this hospital, such as David Weisman.

Top PIs

Clinical Trials running at Abington Neurological Associates

Alzheimer's Disease

Multiple Sclerosis

Dementia

Hallucinations

Alzheimer's Dementia

ACP-204

for Alzheimer's Disease

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patients with ADP * Substudy 1 (Phase 2) will evaluate efficacy and dose response of ACP-204 30 and 60 mg vs placebo. This substudy will be initiated first. * Substudies 2A and 2B (both: Phase 3) will be confirmatory studies of either both doses (ACP-204 30 and 60 mg, respectively) or a single dose from Part 1 vs placebo. Substudies 2A and 2B will be performed independently of each other and will commence after enrollment of Part 1. All 3 substudies will be analyzed independently of each other. Each substudy individually will consist of a screening period (up to 49 days); a double-blind treatment period (6 weeks); a safety follow-up period (30 days) for patients not rolling over into an open-label extension study; and vital status follow-up (for patients who terminated their substudy early).

Recruiting

0 awards

Phase 2 & 3

1 criteria

VHB937

for Alzheimer's Disease

This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.

Recruiting

0 awards

Phase 2

4 criteria